Drugs / Cannabis Extract Oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07459920 | Apr 2026 → Jan 2028 expected | cancer | National Cancer Institute, Naples | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabis Extract Oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07459920 ↗ |
| Known as | Avextra 10/10 | “balanced THC/CBD extract (Cannabis extract Avextra 10/10 oral solution)” NCT07459920 ↗ |
| Route | Oral | “Avextra 10/10 oral solution” NCT07459920 ↗ |